Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Judith C Kando

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Journal of Psychiatric Practice|June 30, 2005
SSRI efficacy-finding the right doseCharles F Caley, Judith C Kando
Neuropsychiatric Disease and Treatment|March 3, 2018
Relationships between clinical scales and binge eating days in adults with moderate to severe binge eating disorder in two Phase III studiesLeslie Citrome, Judith C Kando, Caleb Bliss
Drug Design, Development and Therapy|July 15, 2021
Assessing Palatability of a New Amphetamine Extended-Release Tablet Formulation for the Treatment of ADHDAntonio Pardo, Thomas R King, Eman Rafla, et al.
CNS Spectrums|December 3, 2020
A single-dose, comparative bioavailability study comparing amphetamine extended-release oral suspension with extended-release mixed amphetamine salts capsulesAntonio Pardo, Mohammed Bouhajib, Thomas R King, et al.
CNS Spectrums|January 23, 2020
Single-dose pharmacokinetics of amphetamine extended-release tablets compared with amphetamine extended-release oral suspensionAntonio Pardo, Judith C Kando, Thomas R King, et al.
Journal of Attention Disorders|April 28, 2019
Single-Dose Pharmacokinetics of Amphetamine Extended-Release Oral Suspension in Healthy AdultsBarry K Herman, Mohammed Bouhajib, Thomas R King, et al.
Journal of Child and Adolescent Psychopharmacology|December 22, 2018
Early-Onset Efficacy and Safety Pilot Study of Amphetamine Extended-Release Oral Suspension in the Treatment of Children with Attention-Deficit/Hyperactivity DisorderAnn C Childress, Judith C Kando, Thomas R King, et al.
Journal of Child and Adolescent Psychopharmacology|February 2, 2023
Efficacy of Amphetamine Extended-Release Oral Suspension in Children with Attention-Deficit/Hyperactivity Disorder: Effect Size Across the DayStephen V Faraone, Ann C Childress, Roberto Gomeni, et al.
The Primary Care Companion for CNS Disorders|July 7, 2017
Use and Value of the 7-Item Binge Eating Disorder Screener in Clinical PracticeBarry K Herman, Linda S Deal, Judith C Kando, et al.
The Journal of Clinical Psychiatry|July 20, 2022
Randomized, Double-Blind, Placebo-Controlled, Fixed-Dose Study to Evaluate the Efficacy and Safety of Amphetamine Extended-Release Tablets in Adults With Attention-Deficit/Hyperactivity DisorderAndrew J Cutler, Ann C Childress, Antonio Pardo, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Journal of Psychiatric Practice|June 30, 2005
SSRI efficacy-finding the right doseCharles F Caley, Judith C Kando
Neuropsychiatric Disease and Treatment|March 3, 2018
Relationships between clinical scales and binge eating days in adults with moderate to severe binge eating disorder in two Phase III studiesLeslie Citrome, Judith C Kando, Caleb Bliss
Drug Design, Development and Therapy|July 15, 2021
Assessing Palatability of a New Amphetamine Extended-Release Tablet Formulation for the Treatment of ADHDAntonio Pardo, Thomas R King, Eman Rafla, et al.
CNS Spectrums|December 3, 2020
A single-dose, comparative bioavailability study comparing amphetamine extended-release oral suspension with extended-release mixed amphetamine salts capsulesAntonio Pardo, Mohammed Bouhajib, Thomas R King, et al.
CNS Spectrums|January 23, 2020
Single-dose pharmacokinetics of amphetamine extended-release tablets compared with amphetamine extended-release oral suspensionAntonio Pardo, Judith C Kando, Thomas R King, et al.
Journal of Attention Disorders|April 28, 2019
Single-Dose Pharmacokinetics of Amphetamine Extended-Release Oral Suspension in Healthy AdultsBarry K Herman, Mohammed Bouhajib, Thomas R King, et al.
Journal of Child and Adolescent Psychopharmacology|December 22, 2018
Early-Onset Efficacy and Safety Pilot Study of Amphetamine Extended-Release Oral Suspension in the Treatment of Children with Attention-Deficit/Hyperactivity DisorderAnn C Childress, Judith C Kando, Thomas R King, et al.
Journal of Child and Adolescent Psychopharmacology|February 2, 2023
Efficacy of Amphetamine Extended-Release Oral Suspension in Children with Attention-Deficit/Hyperactivity Disorder: Effect Size Across the DayStephen V Faraone, Ann C Childress, Roberto Gomeni, et al.
The Primary Care Companion for CNS Disorders|July 7, 2017
Use and Value of the 7-Item Binge Eating Disorder Screener in Clinical PracticeBarry K Herman, Linda S Deal, Judith C Kando, et al.
The Journal of Clinical Psychiatry|July 20, 2022
Randomized, Double-Blind, Placebo-Controlled, Fixed-Dose Study to Evaluate the Efficacy and Safety of Amphetamine Extended-Release Tablets in Adults With Attention-Deficit/Hyperactivity DisorderAndrew J Cutler, Ann C Childress, Antonio Pardo, et al.
Pageof 2